Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination drug preparation is an analgesic mixture investigated for the management of postoperative pain, specifically following laparoscopic cholecystectomy. It consists of two local anesthetics, bupivacaine and lidocaine, which provide rapid and prolonged blockade of nerve conduction; epinephrine, a vasoconstrictor added to reduce systemic absorption and extend the duration of the local anesthetic effect; and morphine, an opioid analgesic that provides regional pain relief. In clinical study contexts, this mixture is often soaked into an absorbable hemostatic material, such as Surgicel, which acts as a reservoir for the sustained local release of the medications at the surgical site (e.g., the gallbladder bed or port sites). The preparation was developed and studied by researchers at Assiut University.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + lidocaine + epinephrine + morphine.